Clinical Trials on Pseudohypoparathyroidism Type 1a

Total 56054 results

CymaBay Therapeutics, Inc.

Completed

Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide as Monotherapy

Type 2 Diabetes Mellitus

Russian Federation, Romania, United States, India, Puerto Rico
DiaMedica Therapeutics Inc

Completed

A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients

Diabetes Type 2

Netherlands
Rigshospitalet, Denmark

Completed

Glucolipotoxicity and Type 2 Diabetes

Type 2 Diabetes Mellitus

Denmark
Konkuk University Medical Center

Unknown

A Study to Compare Insulin Pump With Conventional Treatment in Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
RenJi Hospital

Unknown

The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes.

China
Carl T. Hayden VA Medical Center
American Diabetes Association; Amylin Pharmaceuticals, LLC.

Completed

The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled (LEGEND)

Type 2 Diabetes Mellitus

Lebanon, Russian Federation, Ukraine
Novartis Pharmaceuticals

Withdrawn

Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes

Type 2 Diabetes Mellitus
University of California, San Francisco
National Institute of Nursing Research (NINR); University of San Francisco; Donaldina... and other collaborators

Completed

Community Based Participatory Research With Immigrant Chinese With Diabetes

Type 2 Diabetes Mellitus

United States
AstraZeneca

Terminated

Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use (ONGLYZA PMS)

Type 2 Diabetes Mellitus

Philippines
Diabetes Care Center
Animas Corporation

Completed

Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study

Type 2 Diabetes Mellitus

United States
Metabolic Solutions Development Company

Completed

A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator

Type 2 Diabetes Mellitus

United States
Charles Drew University of Medicine and Science
American Diabetes Association

Completed

Dance Dance Revolution (DDR) in Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
West German Center of Diabetes and Health
Novartis Pharmaceuticals; Nintendo of Europe GmbH

Completed

Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Germany
Takeda

Completed

Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Takeda

Completed

Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Takeda

Completed

Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Samsung Medical Center
JW Pharmaceutical

Completed

Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin

Type 2 Diabetes Mellitus

Korea, Republic of
Sanofi

Completed

Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)

Type 2 Diabetes Mellitus

Korea, Republic of
InteKrin Therapeutics, Inc.

Completed

A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator

Type 2 Diabetes Mellitus

United States, Mexico
Phenomix
Forest Laboratories

Terminated

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Type 2 Diabetes

United States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
Adistem Ltd

Unknown

Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 Diabetics

Type 2 Diabetes Mellitus

Philippines
Second Xiangya Hospital of Central South University

Completed

Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D

Type 1 Diabetes Mellitus Maturity Onset

China
Shanghai Jiao Tong University School of Medicine

Completed

A Study of Botulinum Toxin Type A Treatment of Wrinkles in Asian

Botulinum Toxin, Type A
Amgen

Completed

Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study (PERSEIDA)

RAS Wild Type mCRC

Spain
University Hospital, Geneva

Completed

Combined Treatment of Nightmares With Targeted Memory Reactivation and Imagery Rehearsal Therapy

Nightmares, REM-Sleep Type

Switzerland
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients

Type 2 Diabetic Patients
Cairo University

Unknown

Oral Health Awareness and Oral Hygiene in Insulin Dependent Diabetes Mellitus

Health Attitude | Diabetes type1
Barretos Cancer Hospital

Unknown

The Use of Cap-assisted Forward Viewing Endoscopy for Examination of the Ampulla of Vater

Ampulla of Vater Intestinal-Type Adenoma

Brazil
Wang Siqi
China-Japan Friendship Hospital

Not yet recruiting

Research on Changes in Intestinal Barrier Function and Gut Microbiome in Patients With Type 2 Diabetes After Duodenal Mucosal Resurfacing (DMR) (DMR-IBF-GM)

Type 2 Diabetes Mellitus
HighTide Biopharma Pty Ltd

Recruiting

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

China
Brigham and Women's Hospital
National Institute on Minority Health and Health Disparities (NIMHD)

Recruiting

Digital Health Navigation for Latino Patients With Type II Diabetes

Type 2 Diabetes

United States
Biolingus
Chinese University of Hong Kong

Recruiting

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Diabete Type 2

Hong Kong
HighTide Biopharma Pty Ltd
Shenzhen HighTide Biopharmaceutical Ltd.

Completed

A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise

Type 2 Diabetes Mellitus

China
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

Type 2 Diabetes Mellitus

China, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Japan, Czechia, Turkey, Korea, Republic... and more
Eli Lilly and Company

Completed

A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India

Type 2 Diabetes Mellitus

India
Better Therapeutics
Mass General Brigham

Active, not recruiting

A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus (ACTION-DM)

Diabetes Type 2

United States
DyaMX Inc.

Active, not recruiting

Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes (REGENT-1)

Type 2 Diabetes

Australia
Baltimore VA Medical Center
University of Maryland, Baltimore

Active, not recruiting

Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes (EPC-DM)

Type 2 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Sanofi

Completed

Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s) (Lixilan-O-AP)

Type 2 Diabetes Mellitus

China, Korea, Republic of, Malaysia, Taiwan
Sanofi

Completed

Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin (Lixilan-L-CN)

Type 2 Diabetes Mellitus

China
Beth Israel Deaconess Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo... and other collaborators

Completed

Memory Aid by Intranasal Insulin in Diabetes (MemAID) (MemAID)

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy (EDITION AP)

Type 2 Diabetes Mellitus

China, Taiwan, Korea, Republic of
University Health Network, Toronto
Canadian Institutes of Health Research (CIHR); University of Toronto; MOUNT SINAI...

Terminated

Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
Theracos

Completed

Bexagliflozin Efficacy and Safety Trial (BEST)

Type 2 Diabetes Mellitus

United States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan (LIXILAN JP-O1)

Type 2 Diabetes Mellitus

Japan
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

China

3

Subscribe